Osawa, Itsuki
Okamoto, Koh http://orcid.org/0000-0002-4072-9096
Ikeda, Mahoko
Otani, Amato
Wakimoto, Yuji
Yamashita, Marie
Shinohara, Takayuki
Kanno, Yoshiaki
Jubishi, Daisuke
Kurano, Makoto
Harada, Sohei
Okugawa, Shu
Yatomi, Yutaka
Moriya, Kyoji
Article History
Accepted: 3 September 2020
First Online: 12 September 2020
Compliance with ethical standards
:
: Dr. Harada reports personal fees from BD, personal fees from Meiji, personal fees from Shionogi, personal fees from Sumitomo Dainippon Pharma, grants and personal fees from MSD, personal fees from Astellas, personal fees from Beckman Coulter Diagnostics, personal fees from FUJIFILM Toyama Chemical, outside the submitted work.
: The Institutional Review Board of the University of Tokyo approved this study (#3538) and the Institutional Treatment Board of the University of Tokyo Hospital approved the treatment protocol for COVID-19 (#202001CL). Informed consent was obtained from all patients.
Free to read: This content has been made available to all.